TrustCore Financial Services’s Castle Biosciences CSTL Stock Holding History

TrustCore Financial Services’s Portfolio CSTL Stock Details CSTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$3.88M	Buy	164,897 +146	+0.1%	+$3.38K	0.34%	38
2022 Q3	$4.3M	Hold	164,751	–	–	0.41%	32
2022 Q2	$3.62M	Hold	164,751	–	–	0.34%	35
2022 Q1	$7.39M	Buy	164,751 +21,885	+15%	+$904K	0.64%	20
2021 Q4	$6.13M	Hold	142,866	–	–	0.69%	19
2021 Q3	$9.5M	Sell	142,866 -9,608	-6%	-$676K	0.93%	16
2021 Q2	$11.2M	Sell	152,474 -2,000	-1%	-$132K	1.18%	16
2021 Q1	$10.6M	Hold	154,474	–	–	1.23%	16
2020 Q4	$10.4M	Sell	154,474 -48,432	-24%	-$2.63M	1.32%	15
2020 Q3	$10.4M	Sell	202,906 -53,233	-21%	-$2.37M	1.59%	16
2020 Q2	$9.65M	Sell	256,139 -2,613	-1%	-$89.3K	1.67%	13
2020 Q1	$7.71M	Buy	+258,752	New	+$7.81M	1.74%	14

Other funds holding CSTL

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

TrustCore Financial Services's CSTL Position: Q4 2022 in Review

TrustCore Financial Services increased its Castle Biosciences (CSTL) stake by 0.09% in Q4 2022, buying an estimated $3.38K and bringing the position to 164,897 shares worth $3.88M. The position accounts for 0.34% of the portfolio, ranked #38.

TrustCore Financial Services first reported a position in CSTL in Q1 2020 and has held it in 12 quarters since. The position peaked at $11.2M in Q2 2021. 152 funds tracked by Wall St. Rank hold CSTL as of Q4 2022.

TrustCore Financial Services held 164,897 shares of Castle Biosciences worth $3.88M as of Q4 2022.
TrustCore Financial Services bought 146 Castle Biosciences shares in Q4 2022, an estimated $3.38K.
Castle Biosciences made up 0.34% of TrustCore Financial Services's portfolio in Q4 2022, its #38 holding.
TrustCore Financial Services first reported a position in Castle Biosciences in Q1 2020 and has held it in 12 quarters since.
TrustCore Financial Services's Castle Biosciences position peaked at $11.2M in Q2 2021.
152 funds tracked by Wall St. Rank held Castle Biosciences as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.